南非的儿科科里斯处方实践:临床医生调查
Veshni Pillay-Fuentes Lorente1, Trusha Nana2,3, Marianne Black2,4
1Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Southern African journal of infectious diseases
|September 12, 2025
概括
这项研究调查了南非医生对儿科科里斯的使用情况,发现了多样化的剂量做法. 一项新的指导方针旨在标准化南非儿童的素处方.
科学领域:
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
- 儿科 儿科 儿科
背景情况:
- 耐多药性细菌感染构成了全球健康威胁.
- 胆固醇是一种对抗性格拉姆阴性病原体的最后一线治疗方法.
- 目前还没有针对儿科科里斯的处方指南.
研究的目的:
- 调查南非儿科科里斯的处方做法.
- 为了确定儿科科里斯使用的挑战.
- 为制定儿科胆固醇蛋白指导方针提供信息.
主要方法:
- 一项匿名在线调查分发给南非的医疗从业者.
- 这项调查侧重于对14岁及以下的患者的素处方.
- 收集了剂量,经验使用和感知需求的数据.
主要成果:
- 据报道,科里斯的负载和维持剂量各不相同.
- 近一半的受访者在经验上使用了素,许多人继续使用超过72小时.
- 报告指出,人们对随时可用的治疗药物监测有很高的需求.
结论:
- 南非的儿科科里斯处方做法是多样化的.
- 一个新的基于证据的儿科胆固醇指南已经发表.
- 未来的研究将评估指南对处方实践的影响.
相关概念视频
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
214
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
01:29Drug Dosing: Infants and Children
257
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
257
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
249
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
249
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
258
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
258
00:57Antibiotic Selection
59.4K
Overview
59.4K
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
195
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
195